Skip to main content
TMCI logo

TMCI · Treace Medical Concepts, Inc.

$4.00 -0.05 (-1.23%) At close · Jul 24
Market Cap
$259.49M
Shares
64.87M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
John Treace $5,405,190
Mark L. Hair $5,157,046
Sean F. Scanlan $2,310,894
Scot M. Elder $2,123,983
Gaetano M. Guglielmino $468,536
Fiscal 2024
Executive Total
John Treace $6,597,160
Scot M. Elder $4,550,615
Mark L. Hair $4,485,302
Gaetano M. Guglielmino $3,230,098
Sean F. Scanlan $3,085,435
Fiscal 2023
Executive Total
John Treace $8,422,635
Mark L. Hair $4,686,509
Aaron J. Berutti $3,262,358
Scot M. Elder $3,156,616
Sean F. Scanlan $2,949,878
Fiscal 2022
Executive Total
John Treace $3,617,249
Mark L. Hair $1,537,970
Aaron J. Berutti $1,428,785
Sean F. Scanlan $1,338,182
Scot M. Elder $1,321,857
Fiscal 2021
Executive Total
Aaron J. Berutti $1,931,173
Mark L. Hair $1,303,477
John Treace $688,145
Fiscal 2020
Executive Total
Mark L. Hair $1,414,871
John Treace $392,399
Key facts CIK 1630627 CUSIP 89455T109 13F (30d) 14 filings 14 filers Visit website